Please use this identifier to cite or link to this item: http://hdl.handle.net/123456789/4522
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGupta, Vidushi-
dc.date.accessioned2023-08-11T10:42:05Z-
dc.date.available2023-08-11T10:42:05Z-
dc.date.issued2022-
dc.identifier.citationArkivoc, 2022(6), 199-219en_US
dc.identifier.urihttps://doi.org/10.24820/ark.5550190.p011.946-
dc.identifier.urihttp://hdl.handle.net/123456789/4522-
dc.descriptionOnly IISER Mohali authors are available in the record.en_US
dc.description.abstract2-Deoxy-D-glucose (2-DG) is a non-metabolizable glucose analog that has shown promising pharmacological activities and has been used to study the role of glucose in cancer cells. 2-DG is an inhibitor of glycolysis, potential Energy Restriction Mimetic agent and inhibits pathogen-associated molecular patterns. Its radioisotope derivatives have application as tracers. Recently, 2-DG has been used as an anti-COVID-19 drug lowering the need for supplemental oxygen. In this review, different synthetic strategies for preparation of 2- DG including enzymatic synthesis have been discussed. The understanding of these methods would help in developing therapeutics or diagnostic agents aimed at exploring therapeutic targets related with energy metabolism.en_US
dc.language.isoen_USen_US
dc.publisherARKAT USAen_US
dc.subject2-DGen_US
dc.subjectCOVID-19en_US
dc.subjectWarburg effecten_US
dc.subjectaerobic glycolysisen_US
dc.titleA review on synthetic methods for 2-Deoxy-D-glucoseen_US
dc.typeArticleen_US
Appears in Collections:Research Articles

Files in This Item:
File Description SizeFormat 
Need To Add…Full Text_PDF.15.36 kBUnknownView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.